drugset / Trial / NCT02616601

Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis

NCT02616601 ↗

Phase 3 Completed 422 enrolled Actavis Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is to evaluate the efficacy and safety of a generic formulation of fluorouracil 0.5% cream against the brand product (Carac) in participants with actinic keratoses.

Timeline

Start
2015-02-27
Primary completion
2015-09-17
Completion
2015-09-17

Outcome

Met primary endpoint

registry analysis (superiority test); Generic Fluorouracil Cream vs Vehicle Cream; p <0.0001; Fisher Exact NCT02616601 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule 1 g Topical

Indications